Hologic, Inc. (HOLX)
USD 58.46
(-4.59%)
USD 58.46
(-4.59%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | 789.5 Million USD | 73.14% |
| 2023 | 456 Million USD | -64.98% |
| 2022 | 1.3 Billion USD | -30.43% |
| 2021 | 1.87 Billion USD | 67.82% |
| 2020 | 1.11 Billion USD | 2874.13% |
| 2019 | -40.2 Million USD | 63.88% |
| 2018 | -111.3 Million USD | -114.73% |
| 2017 | 755.5 Million USD | 128.39% |
| 2016 | 330.8 Million USD | 151.37% |
| 2015 | 131.6 Million USD | 660.69% |
| 2014 | 17.3 Million USD | 101.48% |
| 2013 | -1.17 Billion USD | -1492.79% |
| 2012 | -73.63 Million USD | -146.86% |
| 2011 | 157.15 Million USD | 350.19% |
| 2010 | -62.81 Million USD | 97.11% |
| 2009 | -2.17 Billion USD | -464.35% |
| 2008 | -385.61 Million USD | -507.72% |
| 2007 | 94.57 Million USD | 244.89% |
| 2006 | 27.42 Million USD | -2.95% |
| 2005 | 28.25 Million USD | 132.29% |
| 2004 | 12.16 Million USD | 322.07% |
| 2003 | 2.88 Million USD | 1510.06% |
| 2002 | 179 Thousand USD | 100.86% |
| 2001 | -20.85 Million USD | -11.98% |
| 2000 | -18.61 Million USD | -403.22% |
| 1999 | -3.7 Million USD | -135.58% |
| 1998 | 10.4 Million USD | -41.24% |
| 1997 | 17.7 Million USD | 55.26% |
| 1996 | 11.4 Million USD | 500.0% |
| 1995 | 1.9 Million USD | -36.67% |
| 1994 | 3 Million USD | 266.67% |
| 1993 | -1.8 Million USD | -220.0% |
| 1992 | 1.5 Million USD | 114.29% |
| 1991 | 700 Thousand USD | -73.08% |
| 1990 | 2.6 Million USD | 85.71% |
| 1989 | 1.4 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q4 | 178.6 Million USD | -8.17% |
| 2024 Q2 | 169.9 Million USD | -31.08% |
| 2024 Q3 | 194.5 Million USD | 14.48% |
| 2024 Q1 | 246.5 Million USD | 172.08% |
| 2023 Q2 | 218.5 Million USD | 16.6% |
| 2023 Q4 | 90.6 Million USD | 323.7% |
| 2023 Q3 | -40.5 Million USD | -118.54% |
| 2023 FY | 456 Million USD | -64.98% |
| 2023 Q1 | 187.4 Million USD | 57.88% |
| 2022 Q4 | 118.7 Million USD | -48.03% |
| 2022 Q3 | 228.4 Million USD | -49.88% |
| 2022 Q1 | 499.2 Million USD | 51.82% |
| 2022 FY | 1.3 Billion USD | -30.43% |
| 2022 Q2 | 455.7 Million USD | -8.71% |
| 2021 FY | 1.87 Billion USD | 67.82% |
| 2021 Q1 | 654.4 Million USD | 32.23% |
| 2021 Q2 | 619.9 Million USD | -5.27% |
| 2021 Q3 | 268.4 Million USD | -56.7% |
| 2021 Q4 | 328.8 Million USD | 22.5% |
| 2020 Q4 | 494.9 Million USD | 258.88% |
| 2020 Q3 | 137.9 Million USD | 43.2% |
| 2020 Q2 | 96.3 Million USD | -75.06% |
| 2020 FY | 1.11 Billion USD | 2874.13% |
| 2020 Q1 | 386.1 Million USD | 867.67% |
| 2019 FY | -40.2 Million USD | 63.88% |
| 2019 Q1 | 98.6 Million USD | 95.25% |
| 2019 Q2 | -272.6 Million USD | -376.47% |
| 2019 Q3 | 93.9 Million USD | 134.45% |
| 2019 Q4 | 39.9 Million USD | -57.51% |
| 2018 Q3 | 112.9 Million USD | 116.57% |
| 2018 Q2 | -681.4 Million USD | -267.54% |
| 2018 Q1 | 406.7 Million USD | 391.78% |
| 2018 FY | -111.3 Million USD | -114.73% |
| 2018 Q4 | 50.5 Million USD | -55.27% |
| 2017 Q2 | 526.8 Million USD | 509.02% |
| 2017 Q3 | 59.5 Million USD | -88.71% |
| 2017 Q4 | 82.7 Million USD | 38.99% |
| 2017 Q1 | 86.5 Million USD | -6.08% |
| 2017 FY | 755.5 Million USD | 128.39% |
| 2016 Q4 | 92.1 Million USD | 8.61% |
| 2016 Q1 | 84.9 Million USD | 238.25% |
| 2016 FY | 330.8 Million USD | 151.37% |
| 2016 Q3 | 84.8 Million USD | 23.08% |
| 2016 Q2 | 68.9 Million USD | -18.85% |
| 2015 Q3 | 29.4 Million USD | -38.49% |
| 2015 Q2 | 47.8 Million USD | 63.7% |
| 2015 Q1 | 29.2 Million USD | 3.91% |
| 2015 FY | 131.6 Million USD | 660.69% |
| 2015 Q4 | 25.1 Million USD | -14.63% |
| 2014 Q3 | 11.3 Million USD | 167.4% |
| 2014 Q4 | 28.1 Million USD | 148.67% |
| 2014 FY | 17.3 Million USD | 101.48% |
| 2014 Q1 | -5.35 Million USD | 99.52% |
| 2014 Q2 | -16.76 Million USD | -213.31% |
| 2013 FY | -1.17 Billion USD | -1492.79% |
| 2013 Q4 | -1.11 Billion USD | -10072.62% |
| 2013 Q3 | -10.95 Million USD | 78.57% |
| 2013 Q2 | -51.1 Million USD | -1739.0% |
| 2013 Q1 | 3.11 Million USD | 104.01% |
| 2012 FY | -73.63 Million USD | -146.86% |
| 2012 Q1 | 20.81 Million USD | -24.51% |
| 2012 Q3 | 23.59 Million USD | 158.59% |
| 2012 Q4 | -77.76 Million USD | -429.6% |
| 2012 Q2 | -40.27 Million USD | -293.51% |
| 2011 Q3 | 36.19 Million USD | -56.1% |
| 2011 Q1 | 10.94 Million USD | 107.99% |
| 2011 Q2 | 82.44 Million USD | 653.61% |
| 2011 FY | 157.15 Million USD | 350.19% |
| 2011 Q4 | 27.56 Million USD | -23.83% |
| 2010 Q2 | 20.61 Million USD | -20.99% |
| 2010 FY | -62.81 Million USD | 97.11% |
| 2010 Q3 | 27.44 Million USD | 33.13% |
| 2010 Q4 | -136.97 Million USD | -599.03% |
| 2010 Q1 | 26.09 Million USD | -25.31% |
| 2009 Q2 | -2.3 Billion USD | -6128.02% |
| 2009 Q1 | 38.15 Million USD | 126.43% |
| 2009 Q3 | 30.75 Million USD | 101.34% |
| 2009 Q4 | 34.94 Million USD | 13.62% |
| 2009 FY | -2.17 Billion USD | -464.35% |
| 2008 Q2 | 55.98 Million USD | 115.61% |
| 2008 Q4 | -144.37 Million USD | -335.22% |
| 2008 Q3 | 61.37 Million USD | 9.63% |
| 2008 Q1 | -358.6 Million USD | -1216.81% |
| 2008 FY | -385.61 Million USD | -507.72% |
| 2007 FY | 94.57 Million USD | 244.89% |
| 2007 Q1 | 16.08 Million USD | 1191.32% |
| 2007 Q2 | 21.63 Million USD | 34.49% |
| 2007 Q3 | 24.74 Million USD | 14.39% |
| 2007 Q4 | 32.11 Million USD | 29.75% |
| 2006 Q1 | 5.71 Million USD | -39.68% |
| 2006 Q4 | -1.47 Million USD | -112.27% |
| 2006 Q3 | 12.01 Million USD | 7.64% |
| 2006 Q2 | 11.16 Million USD | 95.31% |
| 2006 FY | 27.42 Million USD | -2.95% |
| 2005 Q2 | 6.04 Million USD | 32.23% |
| 2005 Q3 | 8.15 Million USD | 34.89% |
| 2005 Q4 | 9.47 Million USD | 16.16% |
| 2005 FY | 28.25 Million USD | 132.29% |
| 2005 Q1 | 4.57 Million USD | -12.21% |
| 2004 Q3 | 3.32 Million USD | 28.43% |
| 2004 Q2 | 2.58 Million USD | 148.94% |
| 2004 Q4 | 5.21 Million USD | 56.69% |
| 2004 Q1 | 1.04 Million USD | -55.44% |
| 2004 FY | 12.16 Million USD | 322.07% |
| 2003 FY | 2.88 Million USD | 1510.06% |
| 2003 Q4 | 2.33 Million USD | 129.05% |
| 2003 Q2 | 383 Thousand USD | 142.0% |
| 2003 Q3 | 1.01 Million USD | 166.06% |
| 2003 Q1 | -912 Thousand USD | 71.18% |
| 2002 Q4 | -3.16 Million USD | -743.29% |
| 2002 Q2 | 4.42 Million USD | 381.37% |
| 2002 Q1 | -1.57 Million USD | 68.07% |
| 2002 FY | 179 Thousand USD | 100.86% |
| 2002 Q3 | 492 Thousand USD | -88.88% |
| 2001 Q3 | -1.21 Million USD | 84.73% |
| 2001 Q4 | -4.92 Million USD | -306.18% |
| 2001 FY | -20.85 Million USD | -11.98% |
| 2001 Q2 | -7.94 Million USD | -17.44% |
| 2001 Q1 | -6.76 Million USD | 38.06% |
| 2000 Q1 | -2.9 Million USD | 6.45% |
| 2000 FY | -18.61 Million USD | -403.22% |
| 2000 Q2 | -2.18 Million USD | 24.69% |
| 2000 Q3 | -2.64 Million USD | -21.02% |
| 2000 Q4 | -10.92 Million USD | -313.24% |
| 1999 Q2 | -1.1 Million USD | -155.0% |
| 1999 FY | -3.7 Million USD | -135.58% |
| 1999 Q1 | 2 Million USD | 53.85% |
| 1999 Q4 | -3.1 Million USD | -106.67% |
| 1999 Q3 | -1.5 Million USD | -36.36% |
| 1998 FY | 10.4 Million USD | -41.24% |
| 1998 Q2 | 2.7 Million USD | 28.57% |
| 1998 Q3 | 4.3 Million USD | 59.26% |
| 1998 Q4 | 1.3 Million USD | -69.77% |
| 1998 Q1 | 2.1 Million USD | -46.15% |
| 1997 Q2 | 4.7 Million USD | 6.82% |
| 1997 Q4 | 3.9 Million USD | -17.02% |
| 1997 Q3 | 4.7 Million USD | 0.0% |
| 1997 FY | 17.7 Million USD | 55.26% |
| 1997 Q1 | 4.4 Million USD | 41.94% |
| 1996 Q2 | 3 Million USD | 130.77% |
| 1996 Q4 | 3.1 Million USD | -20.51% |
| 1996 Q3 | 3.9 Million USD | 30.0% |
| 1996 Q1 | 1.3 Million USD | 116.67% |
| 1996 FY | 11.4 Million USD | 500.0% |
| 1995 Q2 | 200 Thousand USD | -66.67% |
| 1995 Q3 | 500 Thousand USD | 150.0% |
| 1995 Q1 | 600 Thousand USD | 20.0% |
| 1995 Q4 | 600 Thousand USD | 20.0% |
| 1995 FY | 1.9 Million USD | -36.67% |
| 1994 Q2 | 900 Thousand USD | 125.0% |
| 1994 Q1 | 400 Thousand USD | 140.0% |
| 1994 FY | 3 Million USD | 266.67% |
| 1994 Q4 | 500 Thousand USD | -58.33% |
| 1994 Q3 | 1.2 Million USD | 33.33% |
| 1993 Q2 | -200 Thousand USD | 60.0% |
| 1993 FY | -1.8 Million USD | -220.0% |
| 1993 Q4 | -1 Million USD | -400.0% |
| 1993 Q1 | -500 Thousand USD | 0.0% |
| 1993 Q3 | -200 Thousand USD | 0.0% |
| 1992 FY | 1.5 Million USD | 114.29% |
| 1992 Q4 | - USD | -100.0% |
| 1992 Q1 | 300 Thousand USD | 0.0% |
| 1992 Q2 | 500 Thousand USD | 66.67% |
| 1992 Q3 | 700 Thousand USD | 40.0% |
| 1991 Q1 | - USD | 0.0% |
| 1991 Q2 | - USD | 0.0% |
| 1991 Q3 | - USD | 0.0% |
| 1991 Q4 | - USD | 0.0% |
| 1991 FY | 700 Thousand USD | -73.08% |
| 1990 FY | 2.6 Million USD | 85.71% |
| 1990 Q1 | - USD | 0.0% |
| 1990 Q4 | - USD | 0.0% |
| 1990 Q3 | - USD | -100.0% |
| 1990 Q2 | 500 Thousand USD | 0.0% |
| 1989 Q2 | - USD | 0.0% |
| 1989 Q3 | - USD | 0.0% |
| 1989 Q4 | - USD | 0.0% |
| 1989 FY | 1.4 Million USD | 0.0% |
| 1989 Q1 | - USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Akoya Biosciences, Inc. | -63.32 Million USD | 1346.782% |
| AngioDynamics, Inc. | -184.34 Million USD | 528.264% |
| AtriCure, Inc. | -30.43 Million USD | 2693.797% |
| Avinger, Inc. | -18.32 Million USD | 4409.498% |
| Azenta, Inc. | -14.25 Million USD | 5637.631% |
| BioLife Solutions, Inc. | -66.42 Million USD | 1288.523% |
| The Cooper Companies, Inc. | 294.2 Million USD | -168.355% |
| Daxor Corporation | 280.64 Thousand USD | -281221.266% |
| Ekso Bionics Holdings, Inc. | -15.19 Million USD | 5294.762% |
| Femasys Inc. | -14.24 Million USD | 5641.469% |
| GlucoTrack, Inc. | -7.09 Million USD | 11224.419% |
| Harvard Bioscience, Inc. | -3.41 Million USD | 23218.594% |
| ICU Medical, Inc. | -29.65 Million USD | 2762.283% |
| Intuitive Surgical, Inc. | 1.79 Billion USD | 56.09% |
| KORU Medical Systems, Inc. | -13.74 Million USD | 5845.553% |
| LeMaitre Vascular, Inc. | 30.1 Million USD | -2522.488% |
| Innovative Eyewear, Inc. | -6.66 Million USD | 11948.256% |
| Innovative Eyewear, Inc. | -6.66 Million USD | 11948.256% |
| Masimo Corporation | 81.5 Million USD | -868.712% |
| Microbot Medical Inc. | -10.74 Million USD | 7451.024% |
| Meihua International Medical Technologies Co., Ltd. | 11.62 Million USD | -6691.154% |
| Merit Medical Systems, Inc. | 94.41 Million USD | -736.237% |
| Nephros, Inc. | -1.57 Million USD | 50226.984% |
| NovoCure Limited | -207.04 Million USD | 481.322% |
| NEXGEL, Inc. | -3.15 Million USD | 25107.919% |
| NEXGEL, Inc. | -3.15 Million USD | 25107.919% |
| Singular Genomics Systems, Inc. | -94.82 Million USD | 932.63% |
| OraSure Technologies, Inc. | 53.65 Million USD | -1371.438% |
| Pro-Dex, Inc. | 2.12 Million USD | -37018.007% |
| Pulse Biosciences, Inc. | -42.21 Million USD | 1970.41% |
| Predictive Oncology Inc. | -13.98 Million USD | 5745.751% |
| Precision Optics Corporation, Inc. | -2.95 Million USD | 26850.225% |
| QuidelOrtho Corporation | -10.1 Million USD | 7916.832% |
| Repligen Corporation | 41.57 Million USD | -1798.886% |
| Sanara MedTech Inc. | -4.3 Million USD | 18446.824% |
| STAAR Surgical Company | 21.34 Million USD | -3598.412% |
| Sharps Technology, Inc. | -9.84 Million USD | 8122.039% |
| Utah Medical Products, Inc. | 16.63 Million USD | -4646.017% |
| DENTSPLY SIRONA Inc. | -132 Million USD | 698.106% |
| Jin Medical International Ltd. | 2.87 Million USD | -27330.052% |